
AI-powered bloodwork analysis for athletes, coaches, and health-conscious individuals.

Product memo
GearCheck delivers actionable health insights from bloodwork analysis and biomarker tracking, specifically for athletes and coaches. It interprets complex data using athlete-adjusted reference ranges, turning raw lab results into clear health priorities. This approach helps users measures performance and reduce harm, even for those on TRT or specific cycles.
- For who
- Athletes, coaches, and health-conscious individuals
- Solves what
- Actionable health insights from blood work analysis and biomarker tracking.
- AI-powered bloodwork analysis
- Biomarker trend tracking
- Protocol and symptom journaling
In their own words
Complete visibility into your health.
Track your markers. Journal your protocols. Understand what your body is telling you.
AI-powered analysis, trend tracking, and harm reduction for athletes and coaches.
Operator & company
Company
- Founded
May 2026
Operating model
- Business model
Saas
- Platform
Web app
- Audience
Creators
Builder strategy
ProvenRadar analysis
- Strategy Type
- Niche Specialist
- Stage
- Pre Revenue
- Effort
- Solo Buildable
Commercial cues
- Model
- subscription
- Free tier
- Yes
- Trial
- No
Pricing strategy
- • The Yearly plan offers a discount to encourage longer-term commitment.
- • Free tier lowers testing friction.
About Gearcheck Expand
GearCheck offers a specialized platform for athletes, coaches, and health-conscious individuals to gain actionable insights from their bloodwork. It moves beyond standard lab reports by providing AI-powered analysis and biomarker tracking, helping users understand their health data in context.
The platform includes protocol journaling, a health score, and trend charting, allowing for continuous monitoring and informed decision-making. This focus on performance optimization and harm reduction, particularly for those with specific training or supplementation protocols, positions GearCheck as a valuable tool for targeted health management.




